Literature DB >> 9222045

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.

J Vila1, J Ruiz, P Goñi, T Jimenez de Anta.   

Abstract

Mutations in the parC gene, which encodes a subunit of topoisomerase IV, were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone-resistance-determining region of the parC gene from A. baumannii and other bacteria. Nine of ten isolates with MICs of ciprofloxacin of > or = 32 mg/L showed a change of Ser80 to Leu and one showed a change of Glu84 to Lys. These results suggest that ParC from A. baumannii is a secondary target for quinolones and that mutations at residues Ser80 and Glu84, when combined with mutations at Ser83 of GyrA, may render A. baumannii highly resistant to quinolones.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222045     DOI: 10.1093/jac/39.6.757

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  64 in total

1.  Quinolone resistance-determining regions of gyrA and parC in Pasteurella multocida strains with different levels of nalidixic acid resistance.

Authors:  M Cárdenas; J Barbé; M Llagostera; E Miró; F Navarro; B Mirelis; G Prats; I Badiola
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Deletion of TnAbaR23 results in both expected and unexpected antibiogram changes in a multidrug-resistant Acinetobacter baumannii strain.

Authors:  Mandira Kochar; Marialuisa Crosatti; Ewan M Harrison; Barbara Rieck; Jacqueline Chan; Chrystala Constantinidou; Mark Pallen; Hong-Yu Ou; Kumar Rajakumar
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

3.  First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.

Authors:  Laurent Dortet; Rémy A Bonnin; Sandrine Bernabeu; Lélia Escaut; Daniel Vittecoq; Delphine Girlich; Dilek Imanci; Nicolas Fortineau; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters.

Authors:  Xian-Zhong Su; Jing Chen; Tohru Mizushima; Teruo Kuroda; Tomofusa Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

6.  Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.

Authors:  Paul G Higgins; Will Stubbings; Hilmar Wisplinghoff; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2010-01-25       Impact factor: 5.191

7.  Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.

Authors:  H Mouneimné; J Robert; V Jarlier; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 8.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

9.  Rapid determination of quinolone resistance in Acinetobacter spp.

Authors:  Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Jodi M Thomson; Mark D Adams; Karrie Goglin; Philip N Rather; Thuy-Trang D Pennella; Christian Massire; Mark W Eshoo; Rangarajan Sampath; Lawrence B Blyn; David J Ecker; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

10.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.